Evidence map›Paper›PMID 36075018›Full record

ArticleBlood advances2023

Characteristics and outcomes of patients with acute promyelocytic leukemia and extreme hyperleukocytosis at presentation.

Harry J Iland, Nigel Russell, Richard Dillon, Andre C Schuh, Aditya Tedjaseputra, Andrew Wei, Asim Khwaja, Steven Knapper, Steven W Lane, John Reynolds and 15 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Emergencies in Hematology: Why, When and How I Treat?Journal of clinical medicine · 2024
    Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Harry J IlandInstitute of Haematology, Royal Prince Alfred Hospital and University of Sydney, Camperdown, Australia.ORCID 0000-0002-9787-5908
Nigel RussellDepartment of Haematology, Guy's and St Thomas' Hospital, London, United Kingdom.ORCID 0000-0003-1893-8155
Richard DillonDepartment of Medical and Molecular Genetics, Kings College London, London, United Kingdom.ORCID 0000-0001-9333-5296
Andre C SchuhDepartment of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Toronto, Canada.
Aditya TedjaseputraDepartment of Haematology, Alfred Hospital, Melbourne, Australia.ORCID 0000-0001-6224-1940
Andrew WeiDepartment of Haematology, Alfred Hospital, Melbourne, Australia.ORCID 0000-0002-7514-3298
Asim KhwajaDepartment of Haematology, University College Hospital, London, United Kingdom.ORCID 0000-0002-6834-5625
Steven KnapperDivision of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-6405-4441
Steven W LaneCancer Care Services, Royal Brisbane & Women's Hospital and University of Queensland, Brisbane, Australia.ORCID 0000-0002-8050-6209
John ReynoldsAustralian Centre for Blood Diseases, Monash University, Melbourne, Australia.ORCID 0000-0002-8825-8625
Mary Frances McMullinSchool of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, United Kingdom.ORCID 0000-0002-0773-0204
Annalise MartinHaematology Department, Royal Perth Hospital, Perth, Australia.
Peter TanHaematology Department, Royal Perth Hospital, Perth, Australia.
David C TaussigRoyal Marsden Hospital, London, United Kingdom.
Anny WongDepartment of Paediatric Oncology and Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
John TaperDepartment of Haematology, Nepean Hospital, Nepean, Australia.
Christina FragaDivision of Hematology, Department of Medicine, Dalhousie University, Halifax, Canada.
Richard KellyDepartment of Haematology, St James's University Hospital, Leeds, United Kingdom.
Kiran TawanaDepartment of Haematology, Addenbrookes Hospital, Cambridge, United Kingdom.
Priyanka MehtaBristol Haematology and Oncology Centre, University Hospitals of Bristol and Weston NHS Trusts, Bristol, United Kingdom.ORCID 0000-0001-8561-1705
Alain MinaDivision of Bone Marrow Transplant and Cellular Therapies, Department of Medicine, Stanford University, Stanford, CA.
Jessica K AltmanDivision of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.ORCID 0000-0003-1987-1896
Ingolf MølleDepartment of Hematology, Aarhus University Hospital, Aarhus, Denmark.
Sudhir TauroDivision of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, Dundee, United Kingdom.ORCID 0000-0002-7236-970X
Eleni TholouliDepartment of Adult Haematology, Manchester Royal Infirmary, Manchester, United Kingdom.

Funding

Department of Health
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Promyelocytic, AcuteHumansLeukocyte CountLeukocytosis

Identifiers

PMID36075018
PMCPMC10250923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.